Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vilmer

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Archives of Dermatology|March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosisM A Richard, J J Grob, M F Avril, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
British Journal of Haematology|April 1, 1996
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle OsseuseM Cavazzana-Calvo, P Bordigoni, G Michel, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Haematologica|January 12, 2005
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study GroupJean Donadieu, Thierry Leblanc, Brigitte Bader Meunier, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
Blood|September 25, 2003
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951Hélène Cavé, Stefan Suciu, Claude Preudhomme, et al.
British Journal of Haematology|February 26, 2000
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM)M Michallet, M L Tanguy, G Socié, et al.
Leukemia|February 24, 2001
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative GroupE Vilmer, S Suciu, A Ferster, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Archives of Dermatology|March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosisM A Richard, J J Grob, M F Avril, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
British Journal of Haematology|April 1, 1996
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle OsseuseM Cavazzana-Calvo, P Bordigoni, G Michel, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Haematologica|January 12, 2005
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study GroupJean Donadieu, Thierry Leblanc, Brigitte Bader Meunier, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
Blood|September 25, 2003
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951Hélène Cavé, Stefan Suciu, Claude Preudhomme, et al.
British Journal of Haematology|February 26, 2000
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM)M Michallet, M L Tanguy, G Socié, et al.
Leukemia|February 24, 2001
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative GroupE Vilmer, S Suciu, A Ferster, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
Pageof 24